Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study

Archives of Iranian Medicine

Volumn 9, Issue 4, 2006, Pages 319-323

  Mirmomen, Shahram ^a   Alavian, Seyed Moayed ^b,c   Hajarizadeh, Behzad ^c   Kafaee, Jafar ^d   Yektaparast, Babak ^d   Zahedi, Mohammad Javad ^e   Zand, Vahid ^f   Azami, Ali Akbar ^g   Hosseini, Mir Mohammad Ali ^g   Faridi, Ali Reza ^h   Davari, Kambiz ^h   Hajibeigi, Bashir ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Tehran Hepatitis Center   (Iran)

^d Qazvin Blood Transfusion Center   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f Kerman Hepatitis Center   (Iran)

^g Semnan Blood Transfusion Center   (Iran)

^h Zanjan Blood Transfusion Center   (Iran)

Author keywords

Blood transfusion; Hepatitis B; Hepatitis C; Human immunodeficiency virus; Thalassemia

Indexed keywords

FERRITIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BETA THALASSEMIA; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; SCREENING; SEROLOGY; THALASSEMIA MAJOR; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS;

EID: 33751321207     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ardalan FA, Osquei MRF, Toosi MN, Irvanloo G. Synergic effect of chronic hepatitis C infection and beta-thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study. BMC Gastroenterology. 2004; 4: 17.
2. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332: 1463-1466.
3. Costello M, Yungbluth M. Viral infections. In: Henry J B, ed. Clinical Diagnosis and Management by Laboratory Methods. 20th ed. Philadelphia: WB Saunders; 2001: 1064-1066.
4. Angelucci E. Antibodies to hepatitis C virus in thalassemia. Haematologica. 1994; 79: 353-355.
5. Mele A, Stroffolini T, Catapano R, Palumbo F, Moiraghi A, Novaco F. Incidence of transfusion-associated B and non-A, and non-B hepatitis in Italy. Br Med J. 1995; 311: 846-847.
6. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus antibodies among multitransfused thalassemic children in Shiraz, Iran. J Paediatr Child Health. 2001; 37: 564-566.
7. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemic and hemodialysis patients in North Iran-Rasht. J Viral Hepat. 2002; 9: 390-392.
8. Alavian SM, Kafaee J, Yektaparast B, Hajarizadeh B, Doroudi T. The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. Transfusion Today. 2002; 53: 3-4.
9. Al-Fuzae L, Aboolbacker KC, Al-Saleh Q. Beta-thalassemia major in Kuwait. J Trop Pediatr. 1998; 44: 311-312.
10. Al-Mahroos FT, Ebrahim A. Prevalence of hepatitis B, hepatitis C, and human immune deficiency virus markers among patients with hereditary hemolytic anaemias. Ann Trop Paediatr. 1995; 15: 121-128.
11. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C, and human immune deficiency virus markers in multitransfused patients. J Trop Pediatr. 2001; 47: 239-242.
12. Alavian SM, Gholami B, Massarat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case control study. J Gastroenterol Hepatol. 2002; 17: 1092-1097.
13. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992; 327: 369-373.
14. Zali MR. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1998; 2: 290-297.
15. Sen S, Mishra NM, Giri T, Pande I, Khare SD, Kumar A, et al. Acquired immunodeficiency syndrome (AIDS) in multitransfused children with thalassemia. Indian Pediatr. 1993; 30: 455-460.